Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial

Autor: Roy W Beck, Tonya D Riddlesworth, Katrina J Ruedy, Craig Kollman, Andrew J Ahmann, Richard M Bergenstal, Anuj Bhargava, Bruce W Bode, Stacie Haller, Davida F Kruger, Janet B McGill, William Polonsky, David Price, Elena Toschi, Howard Wolpert, Astrid Atakov-Castillo, Edvina Markovic, Stephen Aronoff, Satanya Brooks, Gloria Martinez, Angela Mendez, Theresa Dunnam, Kathy Fitzgerald, Diana Wright, Teck Khoo, Pierre Theuma, Tara Herrold, Debra Thomsen, Richard Bergenstal, Kathleen McCann, Arlene Monk, Char Ashanti, David Liljenquist, Heather Judge, Jean Halford, Davida Kruger, Shiri Levy, Arti Bhan, Terra Cushman, Lameka Dawson, Heather Remtema, Fawn Wolf, James Neifing, Jennifer Murdoch, Susan Staat, Tamara Mayfield, Andrew Ahmann, Bethany Klopfenstein, Farahnaz Joarder, Kathy Hanavan, Jessica Castle, Diana Aby-Daniel, Victoria Morimoto, Donald DeFrang, Bethany Wollam, Janet McGill, Olivia Jordan, Carol Recklein, Mark Kipnes, Terri Ryan, Bruce Bode, Jennifer Boyd, Nitin Rastogi, Katherine Lindmark, William Biggs, Lorena Sandoval, Robin Eifert, Becky Cota, Quang Nguyen, Alejandra Martinez, Cathy Duran, Scott Segel, David Sutton, Miguel Roura, Rebecca Rosenwasser, Jennifer McElveen, Emily Knisely, Anne Johnson, A. Ola Odugbesan, Karla Wardell, Carolyn Paulus, Jack Wahlen, Jon Winkfield, Hilary Wahlen, Emily Hepworth, David Winkfield, Sue Owens, Steven Leichter, Emily Evans, Sarah Konigsberg, Jennifer Rahman, Linda Gaudiani, Natalie Woods, Jesse Cardozo, Kate Wheeler, Jennifer Kane, Terri Eubanks, Katrina Ruedy, Roy W. Beck, Tonya Riddlesworth, Thomas Mouse, Eileen Casal, Claudia Graham

Publikováno v: The Lancet Diabetes & Endocrinology. 5:700-708

Summary Background The benefit of initiation of insulin pump therapy (continuous subcutaneous insulin infusion; CSII) in patients with type 1 diabetes using continuous glucose monitoring (CGM) has not been studied. We aimed to assess glycaemic outcom

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27d901990ceb2b8dfc1cd4fbed435415
https://doi.org/10.1016/s2213-8587(17)30217-6

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections

Autor: Andrew J. Ahmann, Elena Toschi, Janet B. McGill, David Price, Tonya D Riddlesworth, Stacie Haller, William H. Polonsky, Davida F. Kruger, Howard Wolpert, Roy W. Beck, Katrina J. Ruedy, Craig Kollman, Richard M. Bergenstal

Publikováno v: JAMA. 317:371

Importance Previous clinical trials showing the benefit of continuous glucose monitoring (CGM) in the management of type 1 diabetes predominantly have included adults using insulin pumps, even though the majority of adults with type 1 diabetes admini

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::efb12e4f510617198a9b2e5f747ca6a7
https://doi.org/10.1001/jama.2016.19975